Vollständiger Abstract
Worum geht es in dieser Arbeit?
Abstract In a retrospective Nigerian cohort of 33,982 PLHIV initiating or switching to TLD, virological suppression reached 80–82% among participants with available viral load data and 63–65% by intention-to-treat analysis. Suppression was higher among switchers, while age and gender predicted suppression.
Bibliografischer Nachweis
Publikationsdaten
- Autor:innen
- Adam Abdullahi, Edun Martin, Asare Kwabena, Haruna Wisso Abdullahi, Ibrahim Musa Kida, Sophia Osawe, James Onyemata, Sani H Aliyu, Manhattan Charurat, Fatima-Murtala Ibrahim, Victor Adamu, Helen Omuh, Tim Efuntoye, Patrick Dakum, Alash’le Abimiku, Ravindra K Gupta
- Quelle
- Open Forum Infectious Diseases
- Publikation
- 2026-01-01
- Band / Ausgabe
- Nicht angegeben
- Seiten
- Nicht angegeben
- ISSN / ISBN
- 2328-8957
- Zitationen
- 0 laut Crossref
- Referenzen
- 0 hinterlegt
Zitieren
Zitierfähiger Nachweis
Adam Abdullahi, Edun Martin, Asare Kwabena, Haruna Wisso Abdullahi, Ibrahim Musa Kida, Sophia Osawe, James Onyemata, Sani H Aliyu, Manhattan Charurat, Fatima-Murtala Ibrahim, Victor Adamu, Helen Omuh, Tim Efuntoye, Patrick Dakum, Alash’le Abimiku, Ravindra K Gupta (2026). Longitudinal Outcomes of Dolutegravir-based Antiretroviral Therapy in a Large Nigerian Programmatic HIV Cohort, 2017–2019. Open Forum Infectious Diseases. https://doi.org/10.1093/ofid/ofag549
Kontext
Themen, Förderung und Nutzung
Lizenzhinweise: Lizenz 1